These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19734198)

  • 1. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
    Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
    Kubo T; Kuroda Y; Kokubu A; Hosoda F; Arai Y; Hiraoka N; Hirohashi S; Shibata T
    Pancreas; 2009 Oct; 38(7):e200-6. PubMed ID: 19893451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.
    Zang ZJ; Ong CK; Cutcutache I; Yu W; Zhang SL; Huang D; Ler LD; Dykema K; Gan A; Tao J; Lim S; Liu Y; Futreal PA; Grabsch H; Furge KA; Goh LK; Rozen S; Teh BT; Tan P
    Cancer Res; 2011 Jan; 71(1):29-39. PubMed ID: 21097718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
    Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
    Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
    J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization.
    Gorringe KL; Boussioutas A; Bowtell DD;
    Genes Chromosomes Cancer; 2005 Mar; 42(3):247-59. PubMed ID: 15611932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor structural alterations in gastric cancer.
    Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
    BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells.
    Furuta K; Arao T; Sakai K; Kimura H; Nagai T; Tamura D; Aomatsu K; Kudo K; Kaneda H; Fujita Y; Matsumoto K; Yamada Y; Yanagihara K; Sekijima M; Nishio K
    Cancer Sci; 2012 Feb; 103(2):221-7. PubMed ID: 22034905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of
    Calcagno DQ; Takeno SS; Gigek CO; Leal MF; Wisnieski F; Chen ES; Araújo TM; Lima EM; Melaragno MI; Demachki S; Assumpção PP; Burbano RR; Smith MC
    World J Gastroenterol; 2016 Nov; 22(43):9506-9514. PubMed ID: 27920471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
    Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P
    Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling.
    Hodgson JG; Malek T; Bornstein S; Hariono S; Ginzinger DG; Muller WJ; Gray JW
    Cancer Res; 2005 Nov; 65(21):9695-704. PubMed ID: 16266989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis.
    Silva ANS; Coffa J; Menon V; Hewitt LC; Das K; Miyagi Y; Bottomley D; Slaney H; Aoyama T; Mueller W; Arai T; Tan IB; Deng N; Chan XB; Tan P; Tsuburaya A; Sakamaki K; Hayden JD; Yoshikawa T; Zondervan I; Savola S; Grabsch HI
    Ann Surg; 2018 Jan; 267(1):114-121. PubMed ID: 27779515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.
    Wood LD; Calhoun ES; Silliman N; Ptak J; Szabo S; Powell SM; Riggins GJ; Wang TL; Yan H; Gazdar A; Kern SE; Pennacchio L; Kinzler KW; Vogelstein B; Velculescu VE
    Hum Mutat; 2006 Oct; 27(10):1060-1. PubMed ID: 16941478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
    Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
    Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer.
    Iwase T; Tanaka M; Suzuki M; Naito Y; Sugimura H; Kino I
    Biochem Biophys Res Commun; 1993 Jul; 194(2):698-705. PubMed ID: 7688222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.